Pronulife - UriManage - Pharm Rx - Probiotic Blend - GMP

Knowde Enhanced TDS

Identification & Functionality

Ingredient Name: Probiotic Blend
Food Ingredients Functions: Probiotic
Pharma & Nutraceuticals Functions: Probiotic
Technologies: Food Ingredients,
Pharmaceuticals & Nutraceuticals
Product Families: Pharmaceuticals & Nutraceuticals — Nutraceuticals & Supplements
Prebiotics, Probiotics & Postbiotics,
Supplements & Functional Ingredients
Food Ingredients — Nutrition & Fortification
Functional Ingredients,
Prebiotics, Probiotics & Postbiotics

Features & Benefits

Benefit Claims (Health): Decreases LDL Cholesterol,
Reduce Blood Sugar Levels
Food Ingredients Features: Reduction in Blood Glucose Level,
Reduction in Cholesterol
Product Highlights: Clinically proven to reduce serum uric acid, blood sugar, and cholesterol levels
Specific probiotic strains naturally originate from humans
Strain patents in China and USA
Strain deposit: TSF331 at BCC (910815) and CGMCC (15527); TSR332 at BCRC (910816) and CGMCC (15528)

Applications & Uses

Markets: Food & Nutrition,
Healthcare & Pharma
Applications: Healthcare & Pharma — Drug Delivery & Care Solutions
Oral
Food & Nutrition — Nutrition & Well Being
Functional Foods,
Nutraceuticals & Supplements
Dosage Form: Capsules,
Powder & Powder Blends,
Sachets,
Tablets
Food & Nutrition Applications: Dietary Supplements,
Functional Foods
Use Level: 2 x 10¹⁰ CFU
Product Applications: Functional foods and dietary supplements in forms of capsules, tablets, powdered sachets, and others
Uric Acid Control: Refrain serum uric acid, blood sugar, and cholesterol levels

Properties

	Value	Units	Test Method / Conditions
Specification	10¹¹	cfu/g	—

Regulatory & Compliance

Certifications & Compliance: FDA Compliant,
FSSC 22000,
GMP,
Hazard Analysis Critical Control Point (HACCP),
ISO 22000,
NSF Approved

Technical Details & Test Data

Clinical Study: Clinical Study on 53 subjects with uric acid levels more than 8 mg/dL (male) or 5.5 mg/dL (female) for 60 days, with 9 subjects in control group (placebo), 9 subjects in 1st probiotics group (Lactobacillus fermentum TSF331) ), 10 subjects in 2nd probiotics group (Lactobacillus reuteri TSR332), and 25 subjects in 3 probiotics group (PRONULIFE® UriManage) (* p < 0.05, *** p < 0.001, vs. the same group before intervention; # p < 0.05, ### p < 0.001, vs. control)

PRONULIFE® UriManage and Lactobacillus fermentum TSF331 help reduce serum uric acid levels

PRONULIFE® UriManage helps reduce serum uric acid, blood sugar, and cholesterol levels

Storage & Handling